Patent US3697652A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3697652A Expired / Lapsed US ⏱️ 0.0 years remaining

N-acetylglucosamine for treating degenerative afflictions of the joints

Assignee: Rottapharm SpA
•
Filing: 1969-08-19
•
Granted: 1972-10-10
•
Expires: 1989-08-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Pharmaceutical preparations for the treatment of degenerative afflications of the joints, with such preparations containing as the active ingredient one or more N-acyl compounds of aminocarbohydrates.

Inventors

  • 👤 Luigi Rovati
  • 👤 Sergio Mascherpa
  • 👤 Pierluigi Casula

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 12:34
CPC Classifications
C; C07; C07H; C07H13/00; C07H13/02; C07H13/04

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 20 words
A pharmaceutical preparation as defined by claim 1, which is present in the form of an aqueous sterilized injectable solution.
Claim 2
Dependent Claim 12 words
A pharmaceutical preparation as defined by claim 1, further comprising glucosamine hydrochloride.
Claim 3
Dependent Claim 21 words
A pharmaceutical preparation as defined by claim 1, which is present in the form of a capsule to be administered orally.
Claim 4
Independent Claim 38 words
A method for treating degenerative afflictions of the joints which comprises administering internally to the body a pharmaceutical preparation comprising a pharmaceutically acceptable carrier and from 100 mg to 1 gram of an active ingredient consisting of N-acetylglucosamine.
Claim 5
Dependent Claim 29 words
A method for treating degenerative afflictions of the joints as defined by claim 5, wherein said pharmaceutical preparation contains from about 200 to 500 mg. of said active ingredient.
Claim 6
Dependent Claim 59 words
A method for treating degenerative afflictions of the joints as defined by claim 5, wherein said pharmaceutical preparation further comprises from about 0.2 to 4 equivalents per mole of active ingredient of an inorganic salt selected from the group consisting of sodium sulfate, sodium, iodide, and mixtures thereof, said equivalents being based on the anionic constituent of the salt.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1975-10-10 1976-04-10 1976-10-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1979-10-10 1980-04-10 1980-10-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1983-10-10 1984-04-10 1984-10-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag